The legalization of marijuana in many states has opened many perspectives and has led to many ingenious ideas for its use, expanding the range of medicinal marijuana products.
The evidence that cannabis is an effective method to treat painful and chronic conditions is undeniable. In addition, it is more effective than traditional major analgesics, and it can also reduce seizures in severe epilepsy conditions.
However, the revolutionary MedChewRx product is one of its kind and represents a cannabis gum that treats chronic pain, specifically fibromyalgia.
It contains CBD and THC, delivering 5 mg of each. CBD is a non-psychoactive ingredient, so it numbs pain by blocking the pain receptors in the body to avoid its signals in the brain, but it will not “elevate” it.
This gum provides faster effects than smoking, as it bypasses the liver. As soon as CB reacts with saliva, it quickly reaches the bloodstream and is not processed by any other internal organ.
These are some of the benefits of chewing for those who suffer pain:
- Relieve the stress
- Stimulates the cardiovascular system
- It has neuroprotective and neurostimulatory effects on the mind
- Improves cognitive deterioration related to age
In addition, chewing marijuana gum is more socially accepted than smoking, so patients can alleviate their pain anywhere at any time.
Axim Biotechnologies, the company that developed this product, is currently testing its effects but maintains that it will be available for purchase next year.
It is believed that this chewing gum is a faster method of pain relief in the case of painful conditions, especially fibromyalgia, and treats the symptoms as soon as they appear.